| Literature DB >> 21103882 |
Devin W Kehl1, Ramin Farzaneh-Far, Beeya Na, Mary A Whooley.
Abstract
Unrecognized myocardial infarction (MI) carries a poor prognosis in the general population, but its prognostic value is less clear in high-risk patients. We sought to determine whether Q waves on electrocardiogram (ECG), suggestive of unrecognized MI, predict cardiovascular events in patients with stable coronary artery disease (CAD), but without a prior history of MI. We studied 462 patients enrolled in the Heart and Soul Study with stable CAD but without a prior history of MI. All patients had baseline ECGs. The baseline prevalence of unrecognized myocardial infarction was 36%. After a mean of 6.3 years of follow-up, there were a total of 141 cardiovascular events. The presence of Q waves in any ECG lead territory predicted cardiovascular events before (unadjusted HR 1.41, 95% CI 1.01-1.97) and after adjustment for demographics, medical history, diastolic function, and ejection fraction (HR 1.55, 95% CI 1.06-2.26). This association was partly attenuated after adjustment for the presence of inducible ischemia at baseline (HR 1.43, 95% CI 0.96-2.12). When specific territories were analyzed separately, Q waves in anterior leads were predictive of cardiovascular events in both unadjusted and adjusted models (adjusted HR 1.85, 95% CI 1.14-3.00), and this association was partly attenuated after adjustment for inducible ischemia. In conclusion, in patients with CAD but no history of prior MI, the presence of any Q waves or anterior Q waves alone is independently predictive of adverse cardiovascular events.Entities:
Mesh:
Year: 2010 PMID: 21103882 PMCID: PMC3062762 DOI: 10.1007/s00392-010-0255-2
Source DB: PubMed Journal: Clin Res Cardiol ISSN: 1861-0684 Impact factor: 5.460
Baseline characteristics of study population categorized by presence or absence of Q waves
| Variable | No Q waves ( | Any Q wave ( |
|
|---|---|---|---|
| Age (years) | 67 ± 11 | 67 ± 10 | 0.53 |
| Male | 240 (81) | 127 (76) | 0.18 |
| White | 175 (59) | 88 (53) | 0.17 |
| Body mass index (kg/m2) | 28.8 ± 5.2 | 28.5 ± 5.5 | 0.59 |
| Current smoking | 48 (16) | 35 (21) | 0.20 |
| Prior smoking | 144 (50) | 66 (40) | 0.05 |
| Hypertension | 206 (70) | 119 (72) | 0.67 |
| History of congestive heart failure | 28 (9) | 25 (15) | 0.07 |
| History of stroke | 28 (9) | 19 (11) | 0.52 |
| History of diabetes | 77 (26) | 38 (23) | 0.42 |
| Revascularization | 148 (50) | 82 (49) | 0.87 |
| Statin use | 182 (62) | 93 (56) | 0.21 |
| Aspirin use | 221 (75) | 117 (70) | 0.26 |
| Beta-blocker use | 153 (52) | 84 (50) | 0.75 |
| Renin-angiotensin inhibitor use | 128 (43) | 79 (47) | 0.42 |
| Systolic blood pressure (mmHg) | 133.7 ± 19.4 | 135.9 ± 21.4 | 0.27 |
| Diastolic blood pressure (mmHg) | 75.0 ± 11.4 | 76.4 ± 11.8 | 0.21 |
| Left ventricular ejection fraction | 63.8 ± 7.1 | 63.9 ± 8.2 | 0.95 |
| Left ventricular mass index (g/m2) | 94.3 ± 24.7 | 96.8 ± 28.8 | 0.32 |
| Diastolic dysfunction | 25 (10) | 18 (13) | 0.35 |
| Inducible ischemia | 47 (17) | 29 (19) | 0.65 |
| Resting wall motion score | 1.06 ± 0.21 | 1.07 ± 0.21 | 0.62 |
Data reported as N (%) or mean ± standard deviation
Adverse cardiovascular outcomes categorized by presence or absence of Q waves
| OUTCOME | No Q waves ( | Any Q wave ( |
| ||
|---|---|---|---|---|---|
| Total events | Annual rate | Total events | Annual rate | ||
| Cardiovascular events (all-cause death, nonfatal myocardial infarction, or stroke) | 82 | 0.045 | 59 | 0.062 | 0.05 |
| All-cause death | 68 | 0.035 | 48 | 0.047 | 0.17 |
| Nonfatal myocardial infarction | 26 | 0.014 | 17 | 0.017 | 0.56 |
| Stroke | 7 | 0.004 | 7 | 0.007 | 0.25 |
| Congestive heart failure hospitalization | 33 | 0.018 | 27 | 0.028 | 0.11 |
Fig. 1Kaplan–Meier survival curves showing freedom from cardiovascular events (p = 0.05 from log rank test)
Association of Q waves in any territory with cardiovascular events (all-cause death, nonfatal myocardial infarction, stroke)
| Model | Any Q wave HR (95% CI) |
|
|---|---|---|
| Unadjusted | 1.41 (1.01–1.97) | 0.05 |
| Model 1a | 1.39 (0.99–1.94) | 0.06 |
| Model 2b | 1.44 (1.03–2.03) | 0.04 |
| Model 3c | 1.50 (1.04–2.17) | 0.03 |
| Model 4d | 1.55 (1.06–2.26) | 0.02 |
| Model 5e | 1.59 (1.09–2.30) | 0.02 |
| Model 6f | 1.43 (0.96–2.12) | 0.08 |
aModel 1 = Age
bModel 2 = Model 1 + gender, ethnicity, prior smoking
cModel 3 = Model 2 + history of congestive heart failure, diastolic dysfunction
dModel 4 = Model 3 + left ventricular ejection fraction
eModel 5 = Model 3 + wall motion score
fModel 6 = Model 5 + inducible ischemia
Association of Q waves in specific territories with cardiovascular events (all-cause death, nonfatal myocardial infarction, stroke)
| Model | Lateral Q waves HR (95% CI) | Inferior Q waves HR (95% CI) | Anterior Q waves HR (95% CI) |
|---|---|---|---|
| Unadjusted | 1.19 (0.84–1.70) | 1.80 (0.66–4.86) | 1.80 (1.15–2.82) |
| Model 1a | 1.21 (0.85–1.72) | 1.80 (0.66–4.85) | 1.75 (1.12–2.75) |
| Model 2b | 1.24 (0.87–1.78) | 2.10 (0.77–5.77) | 1.88 (1.19–2.96) |
| Model 3c | 1.25 (0.84–1.86) | 2.27 (0.82–6.31) | 1.79 (1.10–2.91) |
| Model 4d | 1.24 (0.83–1.86) | 2.18 (0.79–6.07) | 1.85 (1.14–3.00) |
| Model 5e | 1.32 (0.89–1.96) | 2.11 (0.75–5.94) | 1.80 (1.11–2.93) |
| Model 6f | 1.21 (0.79–1.86) | 2.52 (0.70–9.03) | 1.61 (0.94–2.78) |
aModel 1 = Age
bModel 2 = Model 1 + gender, ethnicity, prior smoking
cModel 3 = Model 2 + history of congestive heart failure, diastolic dysfunction
dModel 4 = Model 3 + left ventricular ejection fraction
eModel 5 = Model 3 + wall motion score
fModel 6 = Model 5 + inducible ischemia
Fig. 2Kaplan–Meier survival curves showing freedom from cardiovascular events (p = 0.006 from log rank test)